Single Agent Oral Selinexor Demonstrates Deep and Durable Responses in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) in Both GCB and Non GCB Subtypes: The Phase 2b Sadal Study

Affiliation auteurs!!!! Error affiliation !!!!
TitreSingle Agent Oral Selinexor Demonstrates Deep and Durable Responses in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) in Both GCB and Non GCB Subtypes: The Phase 2b Sadal Study
Type de publicationJournal Article
Year of Publication2018
AuteursMaerevoet M, Vermaat J, Canales MA, Casasnovas R-O, Van Den Neste E, Goy A, Hill BT, Thieblemont C, De La Cruz MDe Fatima, Cavallo F, Follows G, Choquet S, Gurion R, Bouabdallah R, Jaeger U, Nagy A, Kuruvilla J, Warzocha K, Kalakonda N, Caimi P, Bakhshi S, Ku M, Hamad N, Veelken H, Matczak E, Ma X, Saint-Martin J-R, Shah JJ, Kauffman MG, Shacham S, Zijlstra JM
JournalBLOOD
Volume132
Date PublishedNOV 29
Type of ArticleMeeting Abstract
ISSN0006-4971
DOI10.1182/blood-2018-99-116868